

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.22659496 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.22659496 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.84178832 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.84178832 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 4.84178832 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 4.84178832 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 4.84178832 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.84178832 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.66509116 |
| 10 | detection of molecule of bacterial origin (GO:0032490) | 4.23128336 |
| 11 | leukocyte aggregation (GO:0070486) | 4.19837036 |
| 12 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.14391638 |
| 13 | neutrophil activation involved in immune response (GO:0002283) | 4.10470195 |
| 14 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.94691685 |
| 15 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.80179598 |
| 16 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.74572046 |
| 17 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.65974740 |
| 18 | respiratory burst (GO:0045730) | 3.62531475 |
| 19 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.61969860 |
| 20 | negative regulation of cell killing (GO:0031342) | 3.61969860 |
| 21 | cellular response to ethanol (GO:0071361) | 3.61124728 |
| 22 | detection of external biotic stimulus (GO:0098581) | 3.59449993 |
| 23 | response to muramyl dipeptide (GO:0032495) | 3.54372104 |
| 24 | macrophage activation (GO:0042116) | 3.53974347 |
| 25 | macrophage activation involved in immune response (GO:0002281) | 3.52608751 |
| 26 | positive regulation of interferon-alpha production (GO:0032727) | 3.46605366 |
| 27 | response to peptidoglycan (GO:0032494) | 3.41389386 |
| 28 | immunoglobulin mediated immune response (GO:0016064) | 3.39281512 |
| 29 | detection of bacterium (GO:0016045) | 3.31780842 |
| 30 | regulation of interferon-alpha production (GO:0032647) | 3.31163029 |
| 31 | Golgi transport vesicle coating (GO:0048200) | 3.25706652 |
| 32 | COPI coating of Golgi vesicle (GO:0048205) | 3.25706652 |
| 33 | detection of biotic stimulus (GO:0009595) | 3.20450167 |
| 34 | cellular extravasation (GO:0045123) | 3.19215679 |
| 35 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.17958771 |
| 36 | T-helper 1 type immune response (GO:0042088) | 3.12625810 |
| 37 | response to host (GO:0075136) | 3.08722126 |
| 38 | response to host defenses (GO:0052200) | 3.08722126 |
| 39 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.08722126 |
| 40 | response to type I interferon (GO:0034340) | 3.07404338 |
| 41 | type I interferon signaling pathway (GO:0060337) | 3.06984444 |
| 42 | cellular response to type I interferon (GO:0071357) | 3.06984444 |
| 43 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.05117921 |
| 44 | glycosphingolipid catabolic process (GO:0046479) | 3.03751483 |
| 45 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.00975298 |
| 46 | response to host immune response (GO:0052572) | 3.00975298 |
| 47 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.99775435 |
| 48 | tolerance induction (GO:0002507) | 2.98983641 |
| 49 | T cell migration (GO:0072678) | 2.98459279 |
| 50 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.97258690 |
| 51 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.94718532 |
| 52 | macrophage differentiation (GO:0030225) | 2.93941413 |
| 53 | neutrophil activation (GO:0042119) | 2.92134845 |
| 54 | leukocyte cell-cell adhesion (GO:0007159) | 2.89292559 |
| 55 | response to fungus (GO:0009620) | 2.87567274 |
| 56 | positive regulation of leukocyte degranulation (GO:0043302) | 2.84314041 |
| 57 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.79052876 |
| 58 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.78625533 |
| 59 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.76622990 |
| 60 | glycolipid catabolic process (GO:0019377) | 2.76484669 |
| 61 | granulocyte activation (GO:0036230) | 2.75892008 |
| 62 | RNA destabilization (GO:0050779) | 2.75674027 |
| 63 | regulation of hypersensitivity (GO:0002883) | 2.74341374 |
| 64 | oligosaccharide catabolic process (GO:0009313) | 2.73366174 |
| 65 | myeloid cell activation involved in immune response (GO:0002275) | 2.70980820 |
| 66 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.70470418 |
| 67 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.66049033 |
| 68 | regulation of gamma-delta T cell activation (GO:0046643) | 2.65217585 |
| 69 | regulation of podosome assembly (GO:0071801) | 2.64880425 |
| 70 | defense response to fungus (GO:0050832) | 2.64680474 |
| 71 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.64439034 |
| 72 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.62939204 |
| 73 | microglial cell activation (GO:0001774) | 2.62840108 |
| 74 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.62257281 |
| 75 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.62230372 |
| 76 | * amyloid precursor protein catabolic process (GO:0042987) | 2.59120753 |
| 77 | protein localization to endosome (GO:0036010) | 2.59105706 |
| 78 | germinal center formation (GO:0002467) | 2.58912768 |
| 79 | regulation of vitamin metabolic process (GO:0030656) | 2.58278401 |
| 80 | cellular response to exogenous dsRNA (GO:0071360) | 2.57933471 |
| 81 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.56905689 |
| 82 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.56780082 |
| 83 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.56652030 |
| 84 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.56491304 |
| 85 | positive regulation of interferon-beta production (GO:0032728) | 2.55472903 |
| 86 | regulation of T cell tolerance induction (GO:0002664) | 2.54002225 |
| 87 | regulation of tolerance induction (GO:0002643) | 2.53257328 |
| 88 | positive regulation of mast cell degranulation (GO:0043306) | 2.52577510 |
| 89 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.52577510 |
| 90 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.52423747 |
| 91 | barbed-end actin filament capping (GO:0051016) | 2.51982731 |
| 92 | negative regulation of interleukin-8 production (GO:0032717) | 2.51419720 |
| 93 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.50653479 |
| 94 | response to protozoan (GO:0001562) | 2.50063829 |
| 95 | positive regulation of type 2 immune response (GO:0002830) | 2.50035387 |
| 96 | regulation of antigen processing and presentation (GO:0002577) | 2.49867301 |
| 97 | hepatocyte apoptotic process (GO:0097284) | 2.49595665 |
| 98 | myeloid leukocyte mediated immunity (GO:0002444) | 2.49005382 |
| 99 | regulation of mononuclear cell migration (GO:0071675) | 2.48520879 |
| 100 | modulation by symbiont of host cellular process (GO:0044068) | 2.48100427 |
| 101 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.48098168 |
| 102 | neutrophil chemotaxis (GO:0030593) | 2.47964337 |
| 103 | interferon-gamma secretion (GO:0072643) | 2.47655777 |
| 104 | detection of other organism (GO:0098543) | 2.47490928 |
| 105 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.47404822 |
| 106 | regulation of leukocyte degranulation (GO:0043300) | 2.46531554 |
| 107 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.46135658 |
| 108 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.45918190 |
| 109 | B cell receptor signaling pathway (GO:0050853) | 2.45733344 |
| 110 | cytokine secretion (GO:0050663) | 2.45449669 |
| 111 | myeloid leukocyte activation (GO:0002274) | 2.45421614 |
| 112 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.45194693 |
| 113 | multicellular organism reproduction (GO:0032504) | 2.44790045 |
| 114 | response to laminar fluid shear stress (GO:0034616) | 2.44537229 |
| 115 | regulation of mast cell activation (GO:0033003) | 2.44453043 |
| 116 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.44240002 |
| 117 | NIK/NF-kappaB signaling (GO:0038061) | 2.43924804 |
| 118 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.43511355 |
| 119 | regulation of response to interferon-gamma (GO:0060330) | 2.42792987 |
| 120 | regulation of macrophage cytokine production (GO:0010935) | 2.42786410 |
| 121 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.42645257 |
| 122 | positive regulation of mast cell activation (GO:0033005) | 2.42534593 |
| 123 | neutrophil migration (GO:1990266) | 2.41443430 |
| 124 | positive regulation of macrophage cytokine production (GO:0060907) | 2.41321200 |
| 125 | cellular defense response (GO:0006968) | 2.41153013 |
| 126 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.40938988 |
| 127 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.40693189 |
| 128 | positive regulation of B cell differentiation (GO:0045579) | 2.37533667 |
| 129 | regulation of mast cell degranulation (GO:0043304) | 2.37310482 |
| 130 | positive regulation of lamellipodium assembly (GO:0010592) | 2.37170719 |
| 131 | neutrophil mediated immunity (GO:0002446) | 2.36797451 |
| 132 | lymphocyte chemotaxis (GO:0048247) | 2.36689955 |
| 133 | positive regulation of antigen processing and presentation (GO:0002579) | 2.36329020 |
| 134 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.36274094 |
| 135 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.35216892 |
| 136 | actin nucleation (GO:0045010) | 2.35125036 |
| 137 | positive regulation of lamellipodium organization (GO:1902745) | 2.33314210 |
| 138 | defense response to protozoan (GO:0042832) | 2.33281465 |
| 139 | negative regulation of interleukin-12 production (GO:0032695) | 2.32554209 |
| 140 | leukotriene metabolic process (GO:0006691) | 2.32232042 |
| 141 | peptide catabolic process (GO:0043171) | 2.32108714 |
| 142 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.31841270 |
| 143 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.31444517 |
| 144 | signal peptide processing (GO:0006465) | 2.30583962 |
| 145 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.30049495 |
| 146 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.28381698 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.23285027 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.54869345 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.60937494 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.52264588 |
| 5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.27741862 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.16325747 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.13057998 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.02934670 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.90473578 |
| 10 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.79764566 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.78788370 |
| 12 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.72390866 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.71584973 |
| 14 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.67650718 |
| 15 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.59143901 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.45393233 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.31628227 |
| 18 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.25887397 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.18368033 |
| 20 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.13247033 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 2.10159585 |
| 22 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.01858516 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.99124015 |
| 24 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.96598039 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.95960389 |
| 26 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.92705677 |
| 27 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.92641794 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.89068689 |
| 29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88430413 |
| 30 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.85173767 |
| 31 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.83414131 |
| 32 | MAF_26560356_Chip-Seq_TH1_Human | 1.82952502 |
| 33 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.82056628 |
| 34 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.79410812 |
| 35 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.77716679 |
| 36 | MYB_26560356_Chip-Seq_TH1_Human | 1.75289774 |
| 37 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.70307561 |
| 38 | UTX_26944678_Chip-Seq_JUKART_Human | 1.68636658 |
| 39 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.65855010 |
| 40 | MYC_22102868_ChIP-Seq_BL_Human | 1.60492382 |
| 41 | GATA1_22025678_ChIP-Seq_K562_Human | 1.59540004 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.53158570 |
| 43 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.52940514 |
| 44 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.47350235 |
| 45 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.46848069 |
| 46 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.45836893 |
| 47 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.45589783 |
| 48 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.44283062 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44031264 |
| 50 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.42385012 |
| 51 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.40279506 |
| 52 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39703903 |
| 53 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.37964576 |
| 54 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.36197804 |
| 55 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.29552639 |
| 56 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.28857339 |
| 57 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.26012742 |
| 58 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25761197 |
| 59 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.25641530 |
| 60 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.25418497 |
| 61 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.24348726 |
| 62 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23390334 |
| 63 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22709775 |
| 64 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.22645918 |
| 65 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.22479504 |
| 66 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21303064 |
| 67 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.21070371 |
| 68 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.20087423 |
| 69 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.18533326 |
| 70 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17470192 |
| 71 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17318559 |
| 72 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16439511 |
| 73 | GATA3_26560356_Chip-Seq_TH2_Human | 1.16355342 |
| 74 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.16315006 |
| 75 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13349548 |
| 76 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.13329986 |
| 77 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.12993111 |
| 78 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.12794192 |
| 79 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.11766267 |
| 80 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11557384 |
| 81 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.10885945 |
| 82 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10312651 |
| 83 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.09284542 |
| 84 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09096906 |
| 85 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08106747 |
| 86 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.07352318 |
| 87 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.06946119 |
| 88 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.06812117 |
| 89 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.05789304 |
| 90 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.04078907 |
| 91 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.03605920 |
| 92 | GATA2_19941826_ChIP-Seq_K562_Human | 1.03500787 |
| 93 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.03229344 |
| 94 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.03014152 |
| 95 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.02413771 |
| 96 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01981847 |
| 97 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.01342492 |
| 98 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.01342492 |
| 99 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.00869176 |
| 100 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00780830 |
| 101 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.00660741 |
| 102 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.00631045 |
| 103 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.99693552 |
| 104 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99656107 |
| 105 | TP53_16413492_ChIP-PET_HCT116_Human | 0.99115516 |
| 106 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99063251 |
| 107 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97144484 |
| 108 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97139900 |
| 109 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.97017455 |
| 110 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96923584 |
| 111 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95507058 |
| 112 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.95447851 |
| 113 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.94987685 |
| 114 | GATA1_19941826_ChIP-Seq_K562_Human | 0.94770774 |
| 115 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94173584 |
| 116 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.93760386 |
| 117 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.93760386 |
| 118 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.93011753 |
| 119 | MAF_26560356_Chip-Seq_TH2_Human | 0.92835996 |
| 120 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.92775592 |
| 121 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.92481420 |
| 122 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.92392911 |
| 123 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.91510017 |
| 124 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.91446925 |
| 125 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.89611892 |
| 126 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.87542014 |
| 127 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.86949452 |
| 128 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.85664837 |
| 129 | CJUN_26792858_Chip-Seq_BT549_Human | 0.85580217 |
| 130 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84392268 |
| 131 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.84264835 |
| 132 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.83639218 |
| 133 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.83306432 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 3.18549172 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.17402929 |
| 3 | MP0000685_abnormal_immune_system | 2.77556540 |
| 4 | MP0009785_altered_susceptibility_to | 2.69010238 |
| 5 | MP0003300_gastrointestinal_ulcer | 2.66769109 |
| 6 | MP0003303_peritoneal_inflammation | 2.66713795 |
| 7 | MP0005058_abnormal_lysosome_morphology | 2.63757772 |
| 8 | MP0002419_abnormal_innate_immunity | 2.60708764 |
| 9 | MP0006082_CNS_inflammation | 2.45747927 |
| 10 | MP0005025_abnormal_response_to | 2.45530376 |
| 11 | * MP0005000_abnormal_immune_tolerance | 2.36076235 |
| 12 | MP0005387_immune_system_phenotype | 2.29582375 |
| 13 | MP0001790_abnormal_immune_system | 2.29582375 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 2.26801143 |
| 15 | MP0005671_abnormal_response_to | 2.24340400 |
| 16 | MP0009840_abnormal_foam_cell | 2.20124187 |
| 17 | MP0001533_abnormal_skeleton_physiology | 2.19711988 |
| 18 | * MP0004947_skin_inflammation | 2.16562982 |
| 19 | MP0008260_abnormal_autophagy | 2.15305687 |
| 20 | * MP0002452_abnormal_antigen_presenting | 2.13923431 |
| 21 | MP0003724_increased_susceptibility_to | 2.13466553 |
| 22 | MP0000569_abnormal_digit_pigmentation | 2.10238912 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.03445050 |
| 24 | * MP0002723_abnormal_immune_serum | 2.03308917 |
| 25 | * MP0001800_abnormal_humoral_immune | 2.02647571 |
| 26 | * MP0001819_abnormal_immune_cell | 1.92477218 |
| 27 | * MP0002420_abnormal_adaptive_immunity | 1.91858010 |
| 28 | MP0003183_abnormal_peptide_metabolism | 1.90448531 |
| 29 | MP0010155_abnormal_intestine_physiology | 1.84719029 |
| 30 | MP0003566_abnormal_cell_adhesion | 1.77558085 |
| 31 | MP0000858_altered_metastatic_potential | 1.75274463 |
| 32 | MP0002405_respiratory_system_inflammati | 1.74789259 |
| 33 | * MP0001845_abnormal_inflammatory_respons | 1.70015086 |
| 34 | MP0002933_joint_inflammation | 1.68013989 |
| 35 | MP0000465_gastrointestinal_hemorrhage | 1.64657145 |
| 36 | MP0009333_abnormal_splenocyte_physiolog | 1.64226841 |
| 37 | MP0002006_tumorigenesis | 1.63937139 |
| 38 | MP0005410_abnormal_fertilization | 1.61587119 |
| 39 | MP0008438_abnormal_cutaneous_collagen | 1.61265903 |
| 40 | MP0000920_abnormal_myelination | 1.58937546 |
| 41 | MP0003172_abnormal_lysosome_physiology | 1.58667478 |
| 42 | MP0008004_abnormal_stomach_pH | 1.57057010 |
| 43 | MP0002998_abnormal_bone_remodeling | 1.55850427 |
| 44 | * MP0000604_amyloidosis | 1.55430560 |
| 45 | MP0010234_abnormal_vibrissa_follicle | 1.54922150 |
| 46 | MP0005023_abnormal_wound_healing | 1.54508263 |
| 47 | MP0002139_abnormal_hepatobiliary_system | 1.54438564 |
| 48 | MP0001873_stomach_inflammation | 1.52766083 |
| 49 | MP0000343_altered_response_to | 1.52662524 |
| 50 | MP0005310_abnormal_salivary_gland | 1.48452756 |
| 51 | MP0002166_altered_tumor_susceptibility | 1.47464684 |
| 52 | MP0002138_abnormal_hepatobiliary_system | 1.46777896 |
| 53 | MP0003656_abnormal_erythrocyte_physiolo | 1.46260477 |
| 54 | MP0003448_altered_tumor_morphology | 1.44372499 |
| 55 | MP0002398_abnormal_bone_marrow | 1.43626832 |
| 56 | MP0008469_abnormal_protein_level | 1.41261267 |
| 57 | * MP0000716_abnormal_immune_system | 1.41042715 |
| 58 | MP0003075_altered_response_to | 1.39588812 |
| 59 | MP0003091_abnormal_cell_migration | 1.39544287 |
| 60 | MP0003828_pulmonary_edema | 1.39108118 |
| 61 | MP0003705_abnormal_hypodermis_morpholog | 1.36590500 |
| 62 | * MP0001851_eye_inflammation | 1.36442398 |
| 63 | MP0003763_abnormal_thymus_physiology | 1.34176574 |
| 64 | MP0009384_cardiac_valve_regurgitation | 1.33058056 |
| 65 | MP0005451_abnormal_body_composition | 1.30988511 |
| 66 | MP0005390_skeleton_phenotype | 1.26149346 |
| 67 | MP0002254_reproductive_system_inflammat | 1.26135471 |
| 68 | MP0001958_emphysema | 1.25053834 |
| 69 | MP0002060_abnormal_skin_morphology | 1.22371280 |
| 70 | MP0003191_abnormal_cellular_cholesterol | 1.20526467 |
| 71 | MP0003866_abnormal_defecation | 1.18736257 |
| 72 | * MP0002722_abnormal_immune_system | 1.18696760 |
| 73 | * MP0000689_abnormal_spleen_morphology | 1.16807005 |
| 74 | MP0003453_abnormal_keratinocyte_physiol | 1.16366525 |
| 75 | * MP0002429_abnormal_blood_cell | 1.16081831 |
| 76 | MP0002332_abnormal_exercise_endurance | 1.14035137 |
| 77 | MP0005167_abnormal_blood-brain_barrier | 1.13351468 |
| 78 | MP0001853_heart_inflammation | 1.09117229 |
| 79 | * MP0001216_abnormal_epidermal_layer | 1.08325758 |
| 80 | MP0000490_abnormal_crypts_of | 1.07720892 |
| 81 | MP0005248_abnormal_Harderian_gland | 1.07647238 |
| 82 | MP0002396_abnormal_hematopoietic_system | 1.07228217 |
| 83 | MP0005166_decreased_susceptibility_to | 1.06319788 |
| 84 | MP0004264_abnormal_extraembryonic_tissu | 1.04730532 |
| 85 | MP0005275_abnormal_skin_tensile | 1.04648232 |
| 86 | * MP0003329_amyloid_beta_deposits | 1.03251942 |
| 87 | MP0005076_abnormal_cell_differentiation | 1.02328918 |
| 88 | MP0003690_abnormal_glial_cell | 0.97716747 |
| 89 | MP0009764_decreased_sensitivity_to | 0.96920775 |
| 90 | MP0010352_gastrointestinal_tract_polyps | 0.95942242 |
| 91 | MP0009278_abnormal_bone_marrow | 0.95472446 |
| 92 | MP0003795_abnormal_bone_structure | 0.94693620 |
| 93 | MP0001243_abnormal_dermal_layer | 0.93756369 |
| 94 | MP0004510_myositis | 0.93039053 |
| 95 | MP0003279_aneurysm | 0.93028213 |
| 96 | * MP0000249_abnormal_blood_vessel | 0.90203602 |
| 97 | * MP0002136_abnormal_kidney_physiology | 0.89758915 |
| 98 | MP0003221_abnormal_cardiomyocyte_apopto | 0.89693787 |
| 99 | MP0005409_darkened_coat_color | 0.87979446 |
| 100 | MP0005164_abnormal_response_to | 0.86839626 |
| 101 | MP0005365_abnormal_bile_salt | 0.85984923 |
| 102 | MP0001663_abnormal_digestive_system | 0.85269321 |
| 103 | MP0002796_impaired_skin_barrier | 0.84662556 |
| 104 | MP0005360_urolithiasis | 0.81339714 |
| 105 | * MP0000377_abnormal_hair_follicle | 0.80572639 |
| 106 | MP0000383_abnormal_hair_follicle | 0.80170174 |
| 107 | * MP0009643_abnormal_urine_homeostasis | 0.78328843 |
| 108 | MP0010678_abnormal_skin_adnexa | 0.77887849 |
| 109 | MP0009763_increased_sensitivity_to | 0.76860672 |
| 110 | MP0000703_abnormal_thymus_morphology | 0.76371392 |
| 111 | MP0000371_diluted_coat_color | 0.76356342 |
| 112 | MP0009765_abnormal_xenobiotic_induced | 0.75554387 |
| 113 | MP0005397_hematopoietic_system_phenotyp | 0.75423488 |
| 114 | MP0001545_abnormal_hematopoietic_system | 0.75423488 |
| 115 | MP0004883_abnormal_blood_vessel | 0.73504221 |
| 116 | * MP0006054_spinal_hemorrhage | 0.71510088 |
| 117 | * MP0003634_abnormal_glial_cell | 0.70827745 |
| 118 | MP0002877_abnormal_melanocyte_morpholog | 0.70544456 |
| 119 | MP0003806_abnormal_nucleotide_metabolis | 0.69966605 |
| 120 | MP0001666_abnormal_nutrient_absorption | 0.68289470 |
| 121 | MP0003045_fibrosis | 0.68238360 |
| 122 | MP0004019_abnormal_vitamin_homeostasis | 0.63785501 |
| 123 | MP0005085_abnormal_gallbladder_physiolo | 0.63590991 |
| 124 | MP0008874_decreased_physiological_sensi | 0.63322272 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.17390942 |
| 2 | Spondylolisthesis (HP:0003302) | 4.91914928 |
| 3 | * Recurrent abscess formation (HP:0002722) | 4.59378066 |
| 4 | * Recurrent bacterial skin infections (HP:0005406) | 4.45768193 |
| 5 | Metaphyseal dysplasia (HP:0100255) | 4.11273087 |
| 6 | Abnormality of macrophages (HP:0004311) | 3.99090224 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 3.84685746 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.72176092 |
| 9 | Nasal polyposis (HP:0100582) | 3.59158646 |
| 10 | Myositis (HP:0100614) | 3.49209778 |
| 11 | Absent frontal sinuses (HP:0002688) | 3.43188836 |
| 12 | Amyloidosis (HP:0011034) | 3.39575631 |
| 13 | Orchitis (HP:0100796) | 3.32599843 |
| 14 | Increased cerebral lipofuscin (HP:0011813) | 3.32120407 |
| 15 | Prostate neoplasm (HP:0100787) | 3.12575932 |
| 16 | Dysostosis multiplex (HP:0000943) | 3.02065053 |
| 17 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.01399302 |
| 18 | Abnormality of the nasal mucosa (HP:0000433) | 2.99620177 |
| 19 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.89910132 |
| 20 | Spinal cord lesions (HP:0100561) | 2.84242808 |
| 21 | Syringomyelia (HP:0003396) | 2.84242808 |
| 22 | Retrobulbar optic neuritis (HP:0100654) | 2.83656463 |
| 23 | Optic neuritis (HP:0100653) | 2.83656463 |
| 24 | * Recurrent skin infections (HP:0001581) | 2.82431773 |
| 25 | Gingivitis (HP:0000230) | 2.80580533 |
| 26 | Chronic otitis media (HP:0000389) | 2.80274445 |
| 27 | Recurrent fungal infections (HP:0002841) | 2.79572945 |
| 28 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.75915670 |
| 29 | Mediastinal lymphadenopathy (HP:0100721) | 2.67203047 |
| 30 | Periodontitis (HP:0000704) | 2.65791496 |
| 31 | Systemic lupus erythematosus (HP:0002725) | 2.63577222 |
| 32 | Recurrent viral infections (HP:0004429) | 2.60960219 |
| 33 | * Neurofibrillary tangles (HP:0002185) | 2.59843825 |
| 34 | Gastrointestinal infarctions (HP:0005244) | 2.58564388 |
| 35 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.55291455 |
| 36 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.55291455 |
| 37 | Abnormality of glycolipid metabolism (HP:0010969) | 2.55291455 |
| 38 | Cervical subluxation (HP:0003308) | 2.53097765 |
| 39 | Cellulitis (HP:0100658) | 2.52590626 |
| 40 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.50586600 |
| 41 | Mucopolysacchariduria (HP:0008155) | 2.50586600 |
| 42 | Pustule (HP:0200039) | 2.49829388 |
| 43 | Short middle phalanx of the 5th finger (HP:0004220) | 2.49814556 |
| 44 | Increased IgE level (HP:0003212) | 2.49069821 |
| 45 | Abnormality of the frontal sinuses (HP:0002687) | 2.48721239 |
| 46 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.45964380 |
| 47 | Hemoptysis (HP:0002105) | 2.44559367 |
| 48 | Mutism (HP:0002300) | 2.43860885 |
| 49 | Upper motor neuron abnormality (HP:0002127) | 2.43715208 |
| 50 | Autoimmune thrombocytopenia (HP:0001973) | 2.40698950 |
| 51 | Stomatitis (HP:0010280) | 2.40100339 |
| 52 | Malnutrition (HP:0004395) | 2.39552859 |
| 53 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.37669417 |
| 54 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.37669417 |
| 55 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.37669417 |
| 56 | Interstitial pulmonary disease (HP:0006530) | 2.37311501 |
| 57 | Gingival bleeding (HP:0000225) | 2.34214226 |
| 58 | Chronic obstructive pulmonary disease (HP:0006510) | 2.33745581 |
| 59 | Obstructive lung disease (HP:0006536) | 2.33745581 |
| 60 | Hematochezia (HP:0002573) | 2.33358594 |
| 61 | Fatigue (HP:0012378) | 2.33046720 |
| 62 | Osteolytic defects of the hand bones (HP:0009699) | 2.32692939 |
| 63 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.32692939 |
| 64 | T lymphocytopenia (HP:0005403) | 2.32052371 |
| 65 | Loss of speech (HP:0002371) | 2.31082976 |
| 66 | Recurrent bronchitis (HP:0002837) | 2.28678636 |
| 67 | Myocardial infarction (HP:0001658) | 2.26140952 |
| 68 | Gangrene (HP:0100758) | 2.25747088 |
| 69 | Spontaneous hematomas (HP:0007420) | 2.23148001 |
| 70 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.22784740 |
| 71 | Abnormality of T cell number (HP:0011839) | 2.22337293 |
| 72 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.20770644 |
| 73 | Meningitis (HP:0001287) | 2.18161025 |
| 74 | Peripheral demyelination (HP:0011096) | 2.18035989 |
| 75 | Increased CSF protein (HP:0002922) | 2.15138197 |
| 76 | Arterial tortuosity (HP:0005116) | 2.14630760 |
| 77 | Hepatosplenomegaly (HP:0001433) | 2.08800104 |
| 78 | Peritonitis (HP:0002586) | 2.07612234 |
| 79 | Pulmonary embolism (HP:0002204) | 2.06914904 |
| 80 | Pulmonary infiltrates (HP:0002113) | 2.06817263 |
| 81 | Keratoconjunctivitis sicca (HP:0001097) | 2.06513643 |
| 82 | Supranuclear gaze palsy (HP:0000605) | 2.06439259 |
| 83 | Abnormality of the 2nd finger (HP:0004100) | 2.05937462 |
| 84 | Encephalitis (HP:0002383) | 2.05637210 |
| 85 | Urticaria (HP:0001025) | 2.05514009 |
| 86 | Chest pain (HP:0100749) | 2.04913871 |
| 87 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.04551564 |
| 88 | Vascular tortuosity (HP:0004948) | 2.02958120 |
| 89 | * Diminished motivation (HP:0000745) | 2.02649449 |
| 90 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.02184685 |
| 91 | Subacute progressive viral hepatitis (HP:0006572) | 2.01495852 |
| 92 | Axonal loss (HP:0003447) | 2.00833116 |
| 93 | Aortic aneurysm (HP:0004942) | 1.99812026 |
| 94 | Pathologic fracture (HP:0002756) | 1.99734616 |
| 95 | Thick nail (HP:0001805) | 1.99538149 |
| 96 | Abnormality of the prostate (HP:0008775) | 1.98245865 |
| 97 | Aortic dissection (HP:0002647) | 1.97831921 |
| 98 | Thrombocytosis (HP:0001894) | 1.97184282 |
| 99 | Episodic fever (HP:0001954) | 1.96939947 |
| 100 | Vertebral compression fractures (HP:0002953) | 1.96424606 |
| 101 | * Cerebral inclusion bodies (HP:0100314) | 1.95411542 |
| 102 | Short femoral neck (HP:0100864) | 1.95163412 |
| 103 | Arterial thrombosis (HP:0004420) | 1.94330390 |
| 104 | Petechiae (HP:0000967) | 1.94293532 |
| 105 | * Apathy (HP:0000741) | 1.94199526 |
| 106 | Broad face (HP:0000283) | 1.93090110 |
| 107 | * Inappropriate behavior (HP:0000719) | 1.92891039 |
| 108 | * Neuronal loss in central nervous system (HP:0002529) | 1.92057737 |
| 109 | Hypoplasia of the odontoid process (HP:0003311) | 1.88567254 |
| 110 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.88387378 |
| 111 | Recurrent cutaneous fungal infections (HP:0011370) | 1.88387378 |
| 112 | Skin ulcer (HP:0200042) | 1.86003197 |
| 113 | Glomerulonephritis (HP:0000099) | 1.85995520 |
| 114 | Thickened calvaria (HP:0002684) | 1.85212850 |
| 115 | Cerebral aneurysm (HP:0004944) | 1.85145379 |
| 116 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.84725434 |
| 117 | Autoimmune hemolytic anemia (HP:0001890) | 1.84144990 |
| 118 | IgM deficiency (HP:0002850) | 1.83361262 |
| 119 | Increased IgM level (HP:0003496) | 1.83357959 |
| 120 | Scanning speech (HP:0002168) | 1.82288003 |
| 121 | Vasculitis (HP:0002633) | 1.82113607 |
| 122 | J-shaped sella turcica (HP:0002680) | 1.81957364 |
| 123 | Protrusio acetabuli (HP:0003179) | 1.81498857 |
| 124 | Polyneuropathy (HP:0001271) | 1.80510708 |
| 125 | Bone pain (HP:0002653) | 1.79673988 |
| 126 | Abnormality of the pericardium (HP:0001697) | 1.78963122 |
| 127 | Abnormality of the pleura (HP:0002103) | 1.78463893 |
| 128 | Abnormality of the periventricular white matter (HP:0002518) | 1.78089505 |
| 129 | Leukocytosis (HP:0001974) | 1.76321118 |
| 130 | Abnormal albumin level (HP:0012116) | 1.76268628 |
| 131 | Hypoalbuminemia (HP:0003073) | 1.76268628 |
| 132 | Keratoconjunctivitis (HP:0001096) | 1.76059342 |
| 133 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.75838185 |
| 134 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.75605890 |
| 135 | Coxa vara (HP:0002812) | 1.74330734 |
| 136 | Abnormality of the endocardium (HP:0004306) | 1.73347064 |
| 137 | Onion bulb formation (HP:0003383) | 1.73153815 |
| 138 | Aplasia/hypoplasia of the femur (HP:0005613) | 1.72559487 |
| 139 | Slow saccadic eye movements (HP:0000514) | 1.71772547 |
| 140 | Osteomyelitis (HP:0002754) | 1.71282349 |
| 141 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 1.70259231 |
| 142 | Hypoplastic scapulae (HP:0000882) | 1.70259231 |
| 143 | Thin bony cortex (HP:0002753) | 1.68726889 |
| 144 | * Disinhibition (HP:0000734) | 1.68520112 |
| 145 | Basal ganglia calcification (HP:0002135) | 1.65848832 |
| 146 | Anorexia (HP:0002039) | 1.65812619 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.30298681 |
| 2 | MAP4K1 | 3.08143113 |
| 3 | MST4 | 2.82269191 |
| 4 | STK10 | 2.81103388 |
| 5 | JAK3 | 2.74693352 |
| 6 | TESK1 | 2.49515869 |
| 7 | TRIB3 | 2.40421023 |
| 8 | EPHB1 | 2.39197396 |
| 9 | BLK | 2.31214771 |
| 10 | RIPK1 | 2.29774353 |
| 11 | TYK2 | 2.28207357 |
| 12 | EEF2K | 2.21757668 |
| 13 | TBK1 | 2.17678391 |
| 14 | ZAP70 | 2.02907756 |
| 15 | IRAK3 | 1.99587066 |
| 16 | ACVR1B | 1.92761406 |
| 17 | PRPF4B | 1.90673800 |
| 18 | TXK | 1.83732054 |
| 19 | LRRK2 | 1.71582187 |
| 20 | TAOK3 | 1.68897520 |
| 21 | IRAK4 | 1.59768160 |
| 22 | KIT | 1.56088764 |
| 23 | GRK7 | 1.52811326 |
| 24 | MAP3K1 | 1.51942939 |
| 25 | TGFBR2 | 1.50181127 |
| 26 | YES1 | 1.43719736 |
| 27 | CSF1R | 1.43146959 |
| 28 | JAK1 | 1.42913909 |
| 29 | FGFR4 | 1.40798541 |
| 30 | MAP3K2 | 1.39783916 |
| 31 | BTK | 1.34915026 |
| 32 | IKBKE | 1.34841905 |
| 33 | MAP3K11 | 1.34375962 |
| 34 | GRK6 | 1.31132151 |
| 35 | RIPK4 | 1.27072745 |
| 36 | PIM2 | 1.26474090 |
| 37 | ITK | 1.25011273 |
| 38 | MAP3K8 | 1.24840966 |
| 39 | RPS6KA4 | 1.23465595 |
| 40 | DDR2 | 1.22708300 |
| 41 | MAP3K3 | 1.22310522 |
| 42 | MST1R | 1.16006522 |
| 43 | EPHA3 | 1.15471330 |
| 44 | TESK2 | 1.15376471 |
| 45 | IKBKB | 1.14705742 |
| 46 | TAOK1 | 1.13581056 |
| 47 | MAPKAPK5 | 1.13362261 |
| 48 | CSK | 1.11927672 |
| 49 | CDC42BPA | 1.10548227 |
| 50 | NEK9 | 1.10179339 |
| 51 | MAP2K3 | 1.10100315 |
| 52 | HCK | 1.10080397 |
| 53 | PTK6 | 1.09785992 |
| 54 | IRAK1 | 1.08741616 |
| 55 | KSR2 | 1.02005380 |
| 56 | SYK | 1.00108583 |
| 57 | MAP3K14 | 0.98175724 |
| 58 | PDGFRB | 0.97695629 |
| 59 | KSR1 | 0.97457164 |
| 60 | LCK | 0.94904023 |
| 61 | TAOK2 | 0.92571320 |
| 62 | MAP3K12 | 0.92032521 |
| 63 | PDGFRA | 0.92019532 |
| 64 | RPS6KA2 | 0.91957192 |
| 65 | MET | 0.91608364 |
| 66 | CLK1 | 0.91549002 |
| 67 | MARK2 | 0.91386311 |
| 68 | IRAK2 | 0.90970951 |
| 69 | SGK3 | 0.88627444 |
| 70 | MAPKAPK3 | 0.88455544 |
| 71 | FGFR3 | 0.88446196 |
| 72 | JAK2 | 0.88439306 |
| 73 | MAP3K5 | 0.85598540 |
| 74 | MUSK | 0.84785719 |
| 75 | PAK4 | 0.82323327 |
| 76 | FLT3 | 0.80181045 |
| 77 | PKN2 | 0.79373991 |
| 78 | MAP3K6 | 0.77041698 |
| 79 | STK24 | 0.76771948 |
| 80 | MAPKAPK2 | 0.76677826 |
| 81 | MAP3K13 | 0.75908590 |
| 82 | TRPM7 | 0.75801582 |
| 83 | PTK2B | 0.75679424 |
| 84 | MOS | 0.75455523 |
| 85 | MAP2K4 | 0.75348211 |
| 86 | WNK1 | 0.74394663 |
| 87 | MARK3 | 0.74300996 |
| 88 | PRKD3 | 0.74070675 |
| 89 | CAMKK2 | 0.73308886 |
| 90 | TYRO3 | 0.70860294 |
| 91 | TTN | 0.70179819 |
| 92 | STK3 | 0.69482850 |
| 93 | ERBB3 | 0.69175171 |
| 94 | SGK2 | 0.68980029 |
| 95 | MAPK4 | 0.68707266 |
| 96 | SIK1 | 0.68425270 |
| 97 | CHUK | 0.67896229 |
| 98 | LYN | 0.65553466 |
| 99 | PDK1 | 0.65325290 |
| 100 | FYN | 0.64693284 |
| 101 | PRKG2 | 0.62516410 |
| 102 | KDR | 0.61167968 |
| 103 | DYRK1B | 0.61019089 |
| 104 | PRKCD | 0.60546602 |
| 105 | PDK2 | 0.60469414 |
| 106 | PDK3 | 0.60332079 |
| 107 | PDK4 | 0.60332079 |
| 108 | TEC | 0.60305761 |
| 109 | NEK6 | 0.59229859 |
| 110 | SIK3 | 0.58618876 |
| 111 | RET | 0.57220960 |
| 112 | WNK4 | 0.56405104 |
| 113 | PDPK1 | 0.55972587 |
| 114 | EPHA2 | 0.54890983 |
| 115 | RPS6KA6 | 0.54721645 |
| 116 | CDK12 | 0.53271783 |
| 117 | ERBB4 | 0.53230036 |
| 118 | EPHB2 | 0.52986521 |
| 119 | MAPK7 | 0.51377315 |
| 120 | MELK | 0.50875131 |
| 121 | MAP2K2 | 0.50846876 |
| 122 | EGFR | 0.50784054 |
| 123 | FES | 0.50730431 |
| 124 | DYRK3 | 0.49739844 |
| 125 | NTRK1 | 0.48850793 |
| 126 | MAP2K6 | 0.48355150 |
| 127 | CAMK1D | 0.48200065 |
| 128 | BMPR2 | 0.47016788 |
| 129 | FGR | 0.46944304 |
| 130 | PIM1 | 0.46652553 |
| 131 | TNK2 | 0.46535627 |
| 132 | RPS6KL1 | 0.45490609 |
| 133 | RPS6KC1 | 0.45490609 |
| 134 | MATK | 0.44286685 |
| 135 | IGF1R | 0.43927003 |
| 136 | FER | 0.43755256 |
| 137 | MAPK11 | 0.43649746 |
| 138 | CDK6 | 0.43506712 |
| 139 | ABL1 | 0.43140811 |
| 140 | PASK | 0.42576482 |
| 141 | STK38 | 0.41722167 |
| 142 | ERBB2 | 0.41133426 |
| 143 | PIK3CG | 0.40556676 |
| 144 | BRD4 | 0.40257617 |
| 145 | SGK494 | 0.39729585 |
| 146 | SGK223 | 0.39729585 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.16848440 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.72039614 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.43659947 |
| 4 | Lysosome_Homo sapiens_hsa04142 | 2.33632292 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.24012640 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.22241020 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.21112458 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.16728654 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.02083183 |
| 10 | Legionellosis_Homo sapiens_hsa05134 | 1.88617259 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 1.88362902 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 1.84205077 |
| 13 | Malaria_Homo sapiens_hsa05144 | 1.81492397 |
| 14 | Measles_Homo sapiens_hsa05162 | 1.76143328 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.68490476 |
| 16 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.67604644 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.67280898 |
| 18 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.65749881 |
| 19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.65430509 |
| 20 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.56389197 |
| 21 | Shigellosis_Homo sapiens_hsa05131 | 1.51296276 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.49802028 |
| 23 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.49779140 |
| 24 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.49654744 |
| 25 | Salmonella infection_Homo sapiens_hsa05132 | 1.46454734 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.44129506 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.43167303 |
| 28 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.40302149 |
| 29 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.34469403 |
| 30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.33795601 |
| 31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.30581821 |
| 32 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.30120567 |
| 33 | Phagosome_Homo sapiens_hsa04145 | 1.25910958 |
| 34 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.24667811 |
| 35 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.23073532 |
| 36 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.22557348 |
| 37 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.22490604 |
| 38 | Hepatitis C_Homo sapiens_hsa05160 | 1.20737498 |
| 39 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.17235685 |
| 40 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.17025255 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.16832207 |
| 42 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.14073915 |
| 43 | Viral myocarditis_Homo sapiens_hsa05416 | 1.12381556 |
| 44 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.12251042 |
| 45 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.12176101 |
| 46 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.11616172 |
| 47 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.09970401 |
| 48 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.07945015 |
| 49 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.06510256 |
| 50 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.05378148 |
| 51 | Hepatitis B_Homo sapiens_hsa05161 | 1.03871336 |
| 52 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.03719522 |
| 53 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.02594721 |
| 54 | Apoptosis_Homo sapiens_hsa04210 | 1.00758713 |
| 55 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.98811983 |
| 56 | Histidine metabolism_Homo sapiens_hsa00340 | 0.95013565 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.91893621 |
| 58 | Mineral absorption_Homo sapiens_hsa04978 | 0.90679703 |
| 59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.90161907 |
| 60 | Amoebiasis_Homo sapiens_hsa05146 | 0.89078595 |
| 61 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.87658721 |
| 62 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.86632259 |
| 63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.85542172 |
| 64 | Endocytosis_Homo sapiens_hsa04144 | 0.84692692 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.81981413 |
| 66 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.80123199 |
| 67 | Asthma_Homo sapiens_hsa05310 | 0.80100906 |
| 68 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.80055751 |
| 69 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.75936177 |
| 70 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75046313 |
| 71 | Adherens junction_Homo sapiens_hsa04520 | 0.74675693 |
| 72 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.73728882 |
| 73 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.72749474 |
| 74 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.71885256 |
| 75 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.69231522 |
| 76 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.67373381 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64706879 |
| 78 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64353538 |
| 79 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.63693837 |
| 80 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.63331972 |
| 81 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62215446 |
| 82 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.61580351 |
| 83 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.58827359 |
| 84 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58590302 |
| 85 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.57954329 |
| 86 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57764115 |
| 87 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57593347 |
| 88 | Allograft rejection_Homo sapiens_hsa05330 | 0.56759528 |
| 89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.54109957 |
| 90 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.53170157 |
| 91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.52654961 |
| 92 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.51912606 |
| 93 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.51244112 |
| 94 | * Notch signaling pathway_Homo sapiens_hsa04330 | 0.51037537 |
| 95 | Bladder cancer_Homo sapiens_hsa05219 | 0.50515685 |
| 96 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49157933 |
| 97 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48732069 |
| 98 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.47386761 |
| 99 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.47309641 |
| 100 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.46064965 |
| 101 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46023210 |
| 102 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.45788047 |
| 103 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.45511983 |
| 104 | HTLV-I infection_Homo sapiens_hsa05166 | 0.45291567 |
| 105 | Prion diseases_Homo sapiens_hsa05020 | 0.45149758 |
| 106 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.45109720 |
| 107 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.43212635 |
| 108 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.42055370 |
| 109 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.41843313 |
| 110 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.41621488 |
| 111 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.40540992 |
| 112 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.40117534 |
| 113 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.39186725 |
| 114 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.38869811 |
| 115 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.38501858 |
| 116 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37870441 |
| 117 | Insulin resistance_Homo sapiens_hsa04931 | 0.37244416 |
| 118 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.35958012 |
| 119 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.35370479 |
| 120 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.34772724 |
| 121 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.34567468 |
| 122 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32116726 |
| 123 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.31729436 |
| 124 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.31479052 |
| 125 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.30883669 |
| 126 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.29975160 |

